Loading...
XJPX
7575
Market cap594mUSD
Jul 10, Last price  
1,363.00JPY
1D
-0.87%
1Q
-5.28%
Jan 2017
16.95%
Name

Japan Lifeline Co Ltd

Chart & Performance

D1W1MN
XJPX:7575 chart
P/E
10.23
P/S
1.62
EPS
133.28
Div Yield, %
3.85%
Shrs. gr., 5y
-2.67%
Rev. gr., 5y
2.91%
Revenues
59.19b
+4.55%
18,146,000,00019,840,000,00019,419,000,00022,089,972,00022,361,621,00023,140,947,00021,944,430,00024,371,000,00025,696,000,00030,540,000,00037,181,000,00042,298,000,00045,525,000,00051,761,000,00051,286,000,00051,469,000,00051,750,000,00051,384,000,00056,610,000,00059,187,000,000
Net income
9.35b
+0.35%
508,000,000236,000,000186,000,000562,795,000772,993,000720,517,000519,726,000-202,000,0001,124,000,0002,804,000,0005,350,000,0007,478,000,0007,723,000,0007,748,000,0002,000,000,0007,484,000,0006,891,000,0007,515,000,0009,317,000,0009,350,000,000
CFO
8.17b
-10.33%
358,554,000-169,851,000-169,851,000611,838,0001,273,320,0001,353,624,000816,550,000-374,000,0001,245,000,000916,000,0006,584,000,0004,450,000,0007,037,000,0007,096,000,00011,432,000,00010,246,000,00011,201,000,0006,918,000,0009,113,000,0008,172,000,000
Dividend
Mar 30, 202654 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Japan Lifeline Co., Ltd. is a medical technology firm based in Japan that specializes in cardiovascular healthcare devices. Its operations encompass research, manufacturing, global procurement, and sales of these specialized medical instruments within the country. The company's diverse product range includes solutions for cardiac rhythm management, such as pacemakers, implantable cardioverter defibrillators (including subcutaneous models), cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support tools. For electrophysiology and ablation procedures, Japan Lifeline offers various electrophysiological and ablation catheters (like irrigated tip versions), endoscopic balloon ablation systems, esophageal temperature monitors, internal atrial cardioversion systems, and radio-frequency transseptal needles. Furthermore, its portfolio extends to cardiovascular and endografting products, including vascular, open, and abdominal stent-grafts. In the transvascular intervention segment, the company provides PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and devices for closing atrial septal defects. Complementing these, its gastrointestinal intervention solutions encompass radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Established in 1981, Japan Lifeline Co., Ltd. maintains its headquarters in Tokyo, Japan.
IPO date
Dec 08, 1997
Employees
1,166
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑032025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT